Market closed
Carl Zeiss Meditec/€AFX
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Carl Zeiss Meditec
Carl Zeiss Meditec AG, publicly traded under the ticker symbol AFX, specializes in the healthcare technology sector. Founded in 2002 as a spin-off from Carl Zeiss AG, it provides comprehensive medical solutions for ophthalmology and microsurgery. Operating globally, the company combines its expertise in optics, electronics, and precision engineering to offer innovative products that enhance patient care and clinical outcomes.
Ticker
€AFX
Sector
Trading on
XETRA
Industry
Health Care Equipment & Supplies
Headquarters
Employees
5,730
AFX Metrics
BasicAdvanced
€4B
Market cap
22.78
P/E ratio
€2.01
EPS
1.04
Beta
€1.10
Dividend rate
2.40%
Dividend yield
Price and volume
Market cap
€4B
Beta
1.04
52-week high
€70.05
52-week low
€45.02
Average daily volume
213K
Dividend rate
€1.10
Financial strength
Current ratio
2.132
Quick ratio
1.06
Long term debt to equity
25.615
Total debt to equity
26.931
Dividend payout ratio (TTM)
54.95%
Interest coverage (TTM)
6.37%
Management effectiveness
Return on assets (TTM)
3.65%
Return on equity (TTM)
8.52%
Valuation
Price to earnings (TTM)
22.779
Price to revenue (TTM)
1.97
Price to book
1.96
Price to tangible book (TTM)
5.31
Price to free cash flow (TTM)
42.802
Dividend yield (TTM)
2.40%
Forward dividend yield
2.40%
Growth
Revenue change (TTM)
-1.11%
Earnings per share change (TTM)
-38.05%
3-year revenue growth (CAGR)
7.85%
3-year earnings per share growth (CAGR)
-8.68%
3-year dividend per share growth (CAGR)
-12.64%
What the Analysts think about AFX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Carl Zeiss Meditec stock.
AFX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
AFX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
FAQs
What’s the current market cap for Carl Zeiss Meditec stock?
Carl Zeiss Meditec (AFX) has a market cap of €4B as of December 22, 2024.
What is the P/E ratio for Carl Zeiss Meditec stock?
The price to earnings (P/E) ratio for Carl Zeiss Meditec (AFX) stock is 22.78 as of December 22, 2024.
Does Carl Zeiss Meditec stock pay dividends?
Yes, the Carl Zeiss Meditec (AFX) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is €1.1 and the yield is 2.4%. Carl Zeiss Meditec has a payout ratio of 54.95% on a trailing twelve-month basis.
When is the next Carl Zeiss Meditec dividend payment date?
The next Carl Zeiss Meditec (AFX) dividend payment date is unconfirmed.
What is the beta indicator for Carl Zeiss Meditec?
Carl Zeiss Meditec (AFX) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.